Plug in at the Science Central
Meet our experts in the Science Central, who are eager to field your questions and share the latest news in drug development. Pull up a chair and learn how stronger science can help you tackle your toughest challenges and accelerate getting your product to market and reaching those who need it most.
In addition to expanding upon several of their poster sessions, our scientists will be available to address any of your questions relating to the following areas, and tell you all about what’s new at Charles River.
The immunology groups at Charles River can evaluate a compound’s potential to be an immunomodulatory or immunotoxic. We have experience in the evaluation of monoclonal antibodies, cytokines, proteins, peptides, vaccines and biosimilars.
Chemical and Agrochemical
Specialized and General Toxicology
Our exceptional scientists regularly design and perform safety programs ranging from acute through chronic toxicity and carcinogenicity studies for all program types including inhalation, neurotoxicology, juvenile and developmental, and reproductive testing.
Our Laboratory Sciences team balances scientific integrity, cost-effectiveness and regulatory compliance. Our global capabilities ensure that you have the resources necessary either to handle all your laboratory support needs or simply supplement your in-house capabilities.
In Vitro Toxicology
From inhalation to ocular and dermal assays, our in vitro experts will be available to identify the best model for direct replacement of tests or screenings done on animals leading to better decision-making for your drug development program.
Our team of board-certified pathologists, combined with our multidisciplinary expertise, state-of-the-art technology and depth of experience with large and small molecules and devices enables us to offer a wide array of integrated anatomic and clinical pathology services with the flexibility and timeliness our clients need.
Discovery and Pharmacology
Our scientific team has extensive experience helping clients with the selection of appropriate models and assays, as well as collaborating to design new models to meet the specific needs of a particular compound or discovery program.